A Win For AIM ImmunoTech Inc.

AIM ImmunoTech Inc. (AIM:NYSEMKT) jumped higher at $0.9, a gain of 120.4%. On Mon, Jun 01, 2026, AIM:NYSEMKT hit a New 2-Week High of $0.9. The stock got featured on our News Catalysts scanner on Mon, Jun 01, 2026 at 01:41 PM in the 'BIOTECH' category. From Mon, May 18, 2026, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Mon, Jun 01, 2026 at $1.25 with a volume of 354M+.

About AIM ImmunoTech Inc. (AIM:NYSEMKT)

AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.